Drilldown: Medicines
Medicines > fda max 
:
40 mg/d or
40 mg/d typical; up to 240 mg/d for Zollinger-Ellison
& onset:
Slowing of cognitive decline over 18 months (modest effect, ~27% relative slowing)
:
40 mg/d or
40 mg/d typical; up to 240 mg/d for Zollinger-Ellison
& onset:
Slowing of cognitive decline over 18 months (modest effect, ~27% relative slowing) Use the filters below to narrow your results.
generic:
(There are no values for this filter)
brand:
(There are no values for this filter)
classes:
(There are no values for this filter)
mechanism:
(There are no values for this filter)
uses:
(There are no values for this filter)
starting dose:
(There are no values for this filter)
preparations:
(There are no values for this filter)
fda max: (Click arrow to add another value)
routes:
(There are no values for this filter)
onset: (Click arrow to add another value)
duration:
(There are no values for this filter)
halflife:
(There are no values for this filter)
bioavailability:
(There are no values for this filter)
pregnancy:
(There are no values for this filter)
legal:
(There are no values for this filter)
There are no results for this report.